Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) collected $7.0M revenue from collaborators

On Yesterday, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) +2.08% in trading session and finally closed at $72.56. The firm after opening the first trading session at $71.43 Over the one year trading period, the stock has an above price of $124.21 and it’s below is recorded at $60.27. The company has a market cap of $7.73B. Read More

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) facing $0.59 net loss per ordinary share

Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) closed the trading at a price of $26.43 with the positive change of +4.71%. In the past session approximately 904,533 shares were exchanged against the average daily trading volume of 1,093,050 shares. The stock touched to the maximum level of $26.45, and it reached the lower level of Read More